About the Company
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in both orthobiologic sciences and spinal implants product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SPNE News
Chief executive shakeups: 8 moves in 100 days
Here are eight chief executive shake-ups in the orthopedic and spine industry since the beginning of 2024: 1. Neurosurgeon Adam Kanter, MD, was named executive medical director of Hoag's Pickup Family ...
Theradaptive adds former Orthofix leader as chief scientific officer
Regenerative therapeutics company Theradaptive has appointed Frank Vizesi, PhD, as its chief scientific officer. Dr. Vizesi has over 20 years of experience in orthobiologics and spinal fusion, holding ...
Cruise Operator Viking’s IPO Looks Like a Winner
The company has built a niche in more-exclusive luxury cruising than the mass-market lines. Think string quartets, not string ...
Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering
ZTlido ® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba ® is the subject of an exclusive, transferable license to use the ...
Seanergy Maritime Holdings Corp (SHIP) Rises Higher Than Market: Key Facts
Seanergy Maritime Holdings Corp (SHIP) closed at $9.57 in the latest trading session, marking a +1.27% move from the prior day. The stock outperformed the S&P 500, which registered a daily gain of ...
Private equity firm and pension fund aim to offload $990m in shares in Viking Holdings IPO
Meanwhile, Viking hopes to raise about $235m in net proceeds from the sale of 11m shares through the IPO, in a bid to pay tax ...
Bone Grafts and Substitutes Market Size and Scope, Industry snapshot, Leading Companies and Opportunity Analysis by 2032
Report Ocean recently published a research report titled “Bone Grafts and Substitutes Market” 2024 Forecast to 2032 Analysis by Market Trends.” This study delivers accurate economic projections, ...
Viking Holdings: Cruise Ship IPO Bets The Rich Will Always Float
Viking’s enterprise value would be 13.5 times last year’s EBITDA, higher than the roughly 12 times that Carnival and Royal ...
Aspida Holdings appoints two
Bermudian-based Aspida Holdings Ltd, the life insurance and annuity company, has appointed Jason Pedone as chief technology ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU
New York, New York--(Newsfile Corp. - April 6, 2024) - Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical Holding Corporation ("SeaStar" or the "Company") (NASDAQ: ICU).
Loading the latest forecasts...